Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-002909
Filing Date
2012-03-20
Accepted
2012-03-20 08:18:11
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2208220z10-k.htm 10-K 1277936
2 EX-23.1 a2208220zex-23_1.htm EX-23.1 3655
3 EX-31.1 a2208220zex-31_1.htm EX-31.1 7769
4 EX-31.2 a2208220zex-31_2.htm EX-31.2 7770
5 EX-32.1 a2208220zex-32_1.htm EX-32.1 4891
12 G868665.JPG g868665.jpg GRAPHIC 35423
  Complete submission text file 0001047469-12-002909.txt   3741131

Data Files

Seq Description Document Type Size
6 EX-101.INS path-20111231.xml EX-101.INS 401568
7 EX-101.SCH path-20111231.xsd EX-101.SCH 16123
8 EX-101.CAL path-20111231_cal.xml EX-101.CAL 51959
9 EX-101.LAB path-20111231_lab.xml EX-101.LAB 285290
10 EX-101.PRE path-20111231_pre.xml EX-101.PRE 130327
11 EX-101.DEF path-20111231_def.xml EX-101.DEF 83717
Mailing Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428
Business Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428 484-567-0130
NUPATHE INC. (Filer) CIK: 0001375200 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34836 | Film No.: 12702180
SIC: 2834 Pharmaceutical Preparations